celecoxib has been researched along with Biliary Tract Cancer in 2 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Capecitabine was administered at a dose of 1,000 mg/m(2) b." | 6.74 | Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. ( Bria, E; Carlini, P; Carpanese, L; Cognetti, F; De Marco, S; Gelibter, A; Milella, M; Nuzzo, C; Pino, MS; Ruggeri, EM; Sperduti, I, 2009) |
| "Gemcitabine is an active drug in this disease." | 2.74 | Gemcitabine, irinotecan and celecoxib in patients with biliary cancer. ( Mayo, MS; Smith, HJ; Watkins, JF; Williamson, SK, 2009) |
| "Capecitabine was administered at a dose of 1,000 mg/m(2) b." | 2.74 | Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers. ( Bria, E; Carlini, P; Carpanese, L; Cognetti, F; De Marco, S; Gelibter, A; Milella, M; Nuzzo, C; Pino, MS; Ruggeri, EM; Sperduti, I, 2009) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Watkins, JF | 1 |
| Mayo, MS | 1 |
| Smith, HJ | 1 |
| Williamson, SK | 1 |
| Pino, MS | 1 |
| Milella, M | 1 |
| Gelibter, A | 1 |
| Sperduti, I | 1 |
| De Marco, S | 1 |
| Nuzzo, C | 1 |
| Bria, E | 1 |
| Carpanese, L | 1 |
| Ruggeri, EM | 1 |
| Carlini, P | 1 |
| Cognetti, F | 1 |
2 trials available for celecoxib and Biliary Tract Cancer
| Article | Year |
|---|---|
Gemcitabine, irinotecan and celecoxib in patients with biliary cancer.
Topics: Administration, Oral; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms; | 2009 |
Capecitabine and celecoxib as second-line treatment of advanced pancreatic and biliary tract cancers.
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biliary Tract Neoplasms | 2009 |